Last year, Irish exports of pharmaceuticals amounted to around €125 billion, 40 per cent of national income. The major ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

In the next 10 years, expect the company to do the same while benefiting from greater insurance coverage for CGM -- ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

Investing in attractive dividend growth stocks can lead to superior long-term returns. The two healthcare companies below ...

According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...

Analysts have recently evaluated Elanco Animal Health and provided 12-month price targets. The average target is $15.25, ...

The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...

Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...